AIMSPRO in the Treatment of Bladder Dysfunction in Secondary Progressive Multiple Sclerosis

NCT01228396 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
20
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Daval International Limited